{"version":"1.0","type":"link","title":"FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel for Pancreatic Cancer by BRCA2 and TMB Status: A Japanese C-CAT Database Study.","author_name":"Mizuno K 외","author_url":"https://prs-insight.online/author/Mizuno%20K","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/149285","thumbnail_width":1200,"thumbnail_height":630}